Author

SungWan Chun

Observed names: Chun, Sung Wan, S. Chun, Sung Wan Chun

Institutions: Soonchunhyang University, Soonchunhyang University Hospital Cheonan

Observed institutions: The University of Texas MD Anderson Cancer Center, Soonchunhyang University, Soonchunhyang University Hospital Cheonan

ORCID: 0000-0001-7630-5204

Observed ORCID: 0000-0001-7630-5204

OpenAlex ID: A5102909041

Long‐term efficacy and safety of enavogliflozin in Korean people with type 2 diabetes: A 52‐week extension of a Phase 3 randomized controlled trial

2024 · Soo Heon Kwak, Kyung Ah Han, et al. · Diabetes Obesity and Metabolism · 5

Efficacy and safety of pioglitazone, empagliflozin and glimepiride as third‐line agents in patients with type 2 diabetes inadequately controlled with metformin and DPP ‐4 inhibitors: A multicentre, phase 4 randomized controlled trial

2025 · Yun Kyung Cho, Jae‐Hyoung Cho, et al. · Diabetes Obesity and Metabolism · 2

Efficacy and safety of lobeglitazone added to metformin and sitagliptin combination therapy in patients with type 2 diabetes: A 52‐week, multicentre, randomized, placebo‐controlled, phase III clinical trial

2025 · Eun‐Gyoung Hong, Kyung‐Wan Min, et al. · Diabetes Obesity and Metabolism · 2

Efficacy and safety of combining empagliflozin in people with type 2 diabetes mellitus uncontrolled with metformin and sitagliptin: A randomised, double‐blind, multicentre, therapeutic confirmatory phase 3 clinical trial

2025 · Seung‐Hwan Lee, Kyung Ah Han, et al. · Diabetes Obesity and Metabolism · 1

Author response for "Efficacy and safety of pioglitazone, empagliflozin and glimepiride as third-line agents in patients with type 2 diabetes inadequately controlled with metformin and DPP-4 inhibitors: A multicentre, phase 4 randomized controlled trial"

2025 · Cho, Yun Kyung, Cho, Jae-Hyoung, et al. · Publons reviews and discussion

Author response for "Long‐term efficacy and safety of enavogliflozin in Korean people with type 2 diabetes: A 52‐week extension of a Phase 3 randomized controlled trial"

2024 · Soo Heon Kwak, Kyung Ah Han, et al. · Publons reviews and discussion

P1.20 Metabolic Responses to Metformin in Early-Stage NSCLC Treated with Definitive Radiotherapy: Results of a Phase II Trial

2019 · S. Chun, Z. Liao, et al. · Journal of Thoracic Oncology

Works count: 8

Citation count: 10

H-index: 2

I10-index: